Clinical trial
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With…
NCT00305643 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00305643 |
|---|---|
| Title | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer |
| Official title | A Multicenter Phase III Placebo-Controlled Trial of Celecoxib for Prevention of Capecitabine-Induced Palmar/Plantar (Hand/Foot) Syndrome in Patients With Metastatic Breast and Colorectal Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Pfizer Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Colorectal Cancer, Pain |
| Intervention type | Drug, Procedure |
| Interventions | Capecitabine, Celecoxib, Radiation Therapy, Placebo |
| Enrollment | 11 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 22, 2006 |
| Last update posted | Dec 24, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: